Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Income | $3,898.3M | $4,362.3M | $2,042.2M | $4,578.5M | $5,693.8M | $6,236.0M | $6,088.0M | $5,752.0M | $8,085.0M | $2,629.0M | $2,599.0M | $2,867.0M | $3,185.0M | $1,726.0M | $3,650.0M | $4,532.0M | $5,357.0M | $8,425.0M | $8,362.0M | $6,478.0M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Abbott Laboratories's last 12-month Operating Income is $6,896.0M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Abbott Laboratories's Operating Income growth was 7.5%. The average annual Operating Income growth rates for Abbott Laboratories have been 0.9% over the past three years, 9.9% over the past five years.
Over the last year, Abbott Laboratories's Operating Income growth was 7.5%, which is higher than industry growth of (0.2%). It indicates that Abbott Laboratories's Operating Income growth is Good.